STOCK TITAN

CORRECTION FROM SOURCE: Wellgistics Health Secures $50M ELOC Facility for XRP Treasury Reserve and Real-Time Payments Infrastructure and Other General Ops

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Wellgistics Health (NASDAQ:WGRX) has secured a $50 million Equity Line of Credit (ELOC) to implement XRP cryptocurrency as both a treasury reserve and real-time payments infrastructure. The company aims to revolutionize healthcare payments by leveraging XRP's blockchain technology to enable faster settlements (3-5 seconds vs. 1-3 days for traditional methods), reduced costs ($0.0002 per transfer vs. $10-$30 for bank wires), and enhanced transparency. Key use cases include real-time settlement between pharmacies and suppliers, smart rebates, XRP-backed credit lines, and global vendor payouts. The initiative comes amid growing institutional adoption of XRP, including CME Group's upcoming futures launch, Mastercard's endorsement, and Ripple's expansion in Dubai and Brazil.

CEO Brian Norton emphasizes that this move positions Wellgistics at the intersection of healthcare and fintech, focusing on building efficient infrastructure rather than traditional healthcare assets.

Wellgistics Health (NASDAQ:WGRX) ha ottenuto una linea di credito azionaria (ELOC) da 50 milioni di dollari per implementare la criptovaluta XRP sia come riserva di tesoreria sia come infrastruttura per pagamenti in tempo reale. L'azienda punta a rivoluzionare i pagamenti nel settore sanitario sfruttando la tecnologia blockchain di XRP per consentire liquidazioni più rapide (3-5 secondi contro 1-3 giorni dei metodi tradizionali), costi ridotti (0,0002 $ per trasferimento contro 10-30 $ per bonifici bancari) e maggiore trasparenza. Gli utilizzi principali includono liquidazioni in tempo reale tra farmacie e fornitori, rimborsi intelligenti, linee di credito garantite da XRP e pagamenti globali ai fornitori. L'iniziativa arriva in un contesto di crescente adozione istituzionale di XRP, con il prossimo lancio dei futures da parte di CME Group, il sostegno di Mastercard e l'espansione di Ripple a Dubai e Brasile.

Il CEO Brian Norton sottolinea che questa mossa posiziona Wellgistics all'incrocio tra sanità e fintech, concentrandosi sulla costruzione di infrastrutture efficienti piuttosto che su asset tradizionali nel settore sanitario.

Wellgistics Health (NASDAQ:WGRX) ha asegurado una línea de crédito de capital (ELOC) de 50 millones de dólares para implementar la criptomoneda XRP tanto como reserva de tesorería como infraestructura de pagos en tiempo real. La empresa busca revolucionar los pagos en el sector salud aprovechando la tecnología blockchain de XRP para permitir liquidaciones más rápidas (3-5 segundos frente a 1-3 días en métodos tradicionales), costos reducidos (0,0002 $ por transferencia frente a 10-30 $ por transferencias bancarias) y mayor transparencia. Los casos de uso clave incluyen liquidaciones en tiempo real entre farmacias y proveedores, reembolsos inteligentes, líneas de crédito respaldadas por XRP y pagos globales a proveedores. La iniciativa surge en medio de una creciente adopción institucional de XRP, incluyendo el próximo lanzamiento de futuros por parte de CME Group, el respaldo de Mastercard y la expansión de Ripple en Dubái y Brasil.

El CEO Brian Norton enfatiza que este movimiento posiciona a Wellgistics en la intersección entre salud y fintech, enfocándose en construir infraestructuras eficientes en lugar de activos tradicionales en salud.

Wellgistics Health (NASDAQ:WGRX)는 5천만 달러 규모의 주식 신용 한도(ELOC)를 확보하여 XRP 암호화폐를 재무 준비금과 실시간 결제 인프라로 도입할 계획입니다. 회사는 XRP의 블록체인 기술을 활용해 더 빠른 정산(기존 방식 1-3일 대비 3-5초), 낮은 비용(송금당 0.0002달러, 은행 송금 10~30달러 대비), 그리고 향상된 투명성을 통해 의료 결제 방식을 혁신하려 합니다. 주요 활용 사례로는 약국과 공급업체 간 실시간 정산, 스마트 리베이트, XRP 담보 신용 한도, 글로벌 공급업체 지급 등이 포함됩니다. 이번 이니셔티브는 CME 그룹의 선물 출시 예정, 마스터카드의 지지, 그리고 리플의 두바이 및 브라질 확장 등 XRP의 기관 채택 증가 속에서 이루어졌습니다.

CEO 브라이언 노튼은 이 조치가 전통적 의료 자산 대신 효율적인 인프라 구축에 집중하며 Wellgistics를 의료와 핀테크의 교차점에 위치시킨다고 강조했습니다.

Wellgistics Health (NASDAQ:WGRX) a obtenu une ligne de crédit en actions (ELOC) de 50 millions de dollars pour mettre en œuvre la cryptomonnaie XRP à la fois comme réserve de trésorerie et comme infrastructure de paiements en temps réel. L'entreprise vise à révolutionner les paiements dans le secteur de la santé en exploitant la technologie blockchain de XRP pour permettre des règlements plus rapides (3-5 secondes contre 1-3 jours pour les méthodes traditionnelles), des coûts réduits (0,0002 $ par transfert contre 10-30 $ pour les virements bancaires) et une transparence accrue. Les cas d'utilisation clés comprennent le règlement en temps réel entre pharmacies et fournisseurs, les remises intelligentes, les lignes de crédit garanties par XRP et les paiements mondiaux aux fournisseurs. Cette initiative intervient dans un contexte d'adoption institutionnelle croissante de XRP, notamment avec le lancement prochain des contrats à terme par le CME Group, le soutien de Mastercard et l'expansion de Ripple à Dubaï et au Brésil.

Le PDG Brian Norton souligne que cette démarche positionne Wellgistics à l'intersection de la santé et de la fintech, en se concentrant sur la construction d'infrastructures efficaces plutôt que sur des actifs traditionnels de santé.

Wellgistics Health (NASDAQ:WGRX) hat eine Eigenkapitalkreditlinie (ELOC) in Höhe von 50 Millionen US-Dollar gesichert, um die Kryptowährung XRP sowohl als Treasury-Reserve als auch als Infrastruktur für Echtzeitzahlungen einzusetzen. Das Unternehmen möchte die Gesundheitszahlungen revolutionieren, indem es die Blockchain-Technologie von XRP nutzt, um schnellere Abwicklungen (3-5 Sekunden statt 1-3 Tage bei traditionellen Methoden), geringere Kosten (0,0002 $ pro Überweisung gegenüber 10-30 $ bei Banküberweisungen) und verbesserte Transparenz zu ermöglichen. Wichtige Anwendungsfälle sind Echtzeit-Abwicklung zwischen Apotheken und Lieferanten, intelligente Rabatte, XRP-gesicherte Kreditlinien und weltweite Zahlungen an Anbieter. Die Initiative erfolgt vor dem Hintergrund einer zunehmenden institutionellen Akzeptanz von XRP, darunter der bevorstehende Futures-Start der CME Group, die Unterstützung von Mastercard und die Expansion von Ripple in Dubai und Brasilien.

CEO Brian Norton betont, dass dieser Schritt Wellgistics an die Schnittstelle von Gesundheitswesen und Fintech positioniert und den Fokus auf den Aufbau effizienter Infrastruktur statt traditioneller Gesundheitsvermögenswerte legt.

Positive
  • Implementation of XRP enables ultra-fast 3-5 second transaction settlements vs. traditional 1-3 day transfers
  • Significant cost reduction in transfers ($0.0002 vs. $10-$30 for bank wires)
  • Secured $50M ELOC facility to support the initiative
  • Strategic positioning ahead of competitors in healthcare-fintech integration
  • Multiple revenue opportunities through XRP-backed credit lines and smart rebates
Negative
  • Early adoption of cryptocurrency in healthcare sector carries implementation risks
  • Regulatory uncertainty surrounding cryptocurrency use in healthcare payments
  • Potential volatility in XRP value could affect treasury reserves

Insights

Wellgistics adopts XRP for treasury and payments with $50M ELOC; offers potential benefits despite implementation uncertainties.

Wellgistics Health's initiative to incorporate XRP into its operations represents a significant strategic pivot that merges healthcare infrastructure with blockchain technology. The $50 million Equity Line of Credit facility isn't merely capital raising—it's the foundation for what appears to be a comprehensive infrastructure overhaul intended to address fundamental inefficiencies in healthcare payments.

The company's rationale for XRP adoption centers on compelling technical advantages: settlement in 3-5 seconds versus days for traditional banking, transaction costs of 0.0002% versus $10-30 for wires, and inherent transparency through the XRP Ledger. These features directly target healthcare's notorious payment friction points—slow reimbursements, high transaction costs, and opaque payment tracking.

However, this announcement reveals more about intention than implementation. While the company presents a detailed vision, the press release uses future-oriented language ("upon successful commercialization") indicating this remains largely conceptual. The $50M ELOC provides flexibility to fund this initiative alongside "other general ops," suggesting gradual rather than immediate deployment.

The market context section tellingly lists upcoming developments rather than established precedents (CME futures launch, Mastercard's identification of XRP as a bridge currency), highlighting both the innovative nature of this approach and its speculative elements. Wellgistics is positioning itself at the intersection of two high-growth sectors—healthcare infrastructure and blockchain-based financial systems—but the execution timeline and regulatory considerations remain undefined.

For a pharmaceutical distribution company to adopt cryptocurrency for treasury reserves represents a significant departure from industry norms. While the efficiency benefits are compelling, the company will need to navigate regulatory complexity in both healthcare and cryptocurrency domains. The initiative shows ambition but requires careful execution to deliver on its promised transformation of healthcare payments infrastructure.

The correction is to the headline only

TAMPA, FL / ACCESS Newswire / May 8, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner.

This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity and on-demand financial infrastructure designed to eliminate banking delays, reduce cost, and increase transparency across its national healthcare network.

"At Wellgistics Health, we challenge the idea that healthcare has to be tethered to legacy systems, bloated intermediaries, and slow-moving money," said Brian Norton, CEO of Wellgistics Health. "We are developing a platform that connects manufacturers directly to pharmacies and patients-bypassing the red tape and placing control back in the hands of those who deliver care. Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that's long been starved of all three. I believe that the future winners in healthcare won't be the companies with the biggest buildings…they'll be those with the fastest rails, cleanest data, and most efficient platforms. We're betting on infrastructure…not inertia."

Why XRP? Why Now?

We believe that there are certain advantages to integrating XRP and its related infrastructure into its healthcare ecosystem. These include, among others:

  • Speed: XRP settles transactions in 3-5 seconds vs. 1-3 days for ACH or wire transfers, allowing for near real-time settlement among pharmacies, suppliers, and manufacturers.

  • Cost: Less than $0.0002 per transfer vs. $10-$30 for standard bank wires.

  • Transparency: All transactions are logged on the XRP Ledger for real-time compliance, rebate tracking, and auditability.

  • Scope: Supports global vendor payouts with significantly low foreign exchange and wire transfer fees.

  • Flexibility: Allows for XRP-backed lines of credit to support independent pharmacy liquidity.

These benefits will support faster vendor payments, performance-based rebates, and embedded liquidity tools for pharmacies and manufacturers in the Wellgistics ecosystem.

Use Cases Across the Ecosystem

  • Real-time settlement between pharmacies, suppliers, and manufacturers

  • Smart rebates calculated automatically based on real-world data

  • XRP-backed credit lines to enhance liquidity for independent pharmacies

  • Global vendor payouts with near-zero foreign transaction and wire costs

  • Immutable compliance layer supporting DSCSA reporting and pricing validation

"We're working to unlock capital velocity with surgical precision," said Mark DiSiena, CFO of Wellgistics Health. "We believe that our XRP-powered infrastructure will allow us to run leaner, faster, and with more control than any of our peers in pharma infrastructure."

The Market Is Moving-And Wellgistics Intends to Lead

XRP is gaining momentum across global institutions, as demonstrated by the following:

  1. CME Group to launch XRP futures for institutional access
    → CME will launch cash-settled XRP futures contracts in May 2025 to meet rising institutional demand.¹

  2. Mastercard identifies XRP as a bridge currency for cross-border payments
    → Mastercard's 2025 report highlights XRP as a top solution for global remittances and cost efficiency.²

  3. Ripple acquires prime brokerage firm Hidden Road for $1.25B
    → This landmark acquisition expands XRP's footprint in institutional liquidity and asset servicing.³

  4. Ripple receives regulatory licensing in Dubai
    → Ripple became the first blockchain payment provider licensed by the DFSA to operate crypto-based financial services in the UAE.⁴

  5. Ripple expands real-world cross-border payment corridors in Brazil and Portugal
    → Ripple now enables live XRP-powered remittances between LATAM and Europe through its partnership with Unicâmbio.⁵

"Others are waiting for change. We're building it," Norton added. "I strongly believe that our XRP initiative positions Wellgistics Health years ahead of the curve-and squarely at the center of where healthcare and fintech converge."

About Wellgistics Health

Wellgistics Health, Inc. (NASDAQ:WGRX) is a publicly traded healthcare infrastructure company transforming how medications move, get priced, and reach patients. The company operates across pharmaceutical distribution, prescription technology, and clinical fulfillment-connecting over 150 direct manufacturer contracts to a growing network of more than 6,000 independent pharmacies nationwide.

Wellgistics Health delivers real-time prescription hub services, compliance-driven logistics, and patient-first fulfillment models, while equipping pharmacies with embedded financial, clinical, and digital tools. Its integrated platform supports a wide range of therapeutic categories-from specialty-lite to maintenance meds-by eliminating friction, accelerating reimbursements, and creating direct, transparent pathways between manufacturers, providers, pharmacies, and patients.

For more information, visit: www.wellgisticshealth.com.

Forward-Looking Statements

This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at www.sec.gov.

Media Contact: media@wellgisticshealth.com
Investor Relations: investors@wellgisticshealth.com

References

  1. CME Group Press Release: CME to Launch XRP Futures

  2. AInvest: Mastercard Identifies XRP as Bridge Currency

  3. Reuters: Ripple Acquires Hidden Road for $1.25B

  4. BusinessWire: Ripple Licensed by DFSA in Dubai

  5. PYMNTS: Ripple Launches Portugal-Brazil Corridor

SOURCE: Wellgistics Health, Inc.



View the original press release on ACCESS Newswire

FAQ

What is Wellgistics Health's (WGRX) plan for the $50M ELOC facility?

Wellgistics Health plans to use the $50M ELOC to develop and implement XRP as a treasury reserve and real-time payments infrastructure, aiming to eliminate banking delays, reduce costs, and increase transparency across its healthcare network.

How much faster are XRP transactions compared to traditional banking for WGRX?

XRP settles transactions in 3-5 seconds, compared to 1-3 days for traditional ACH or wire transfers, offering near real-time settlement capabilities.

What are the cost savings of using XRP for Wellgistics Health transactions?

XRP transactions cost less than $0.0002 per transfer, compared to $10-$30 for standard bank wires, representing significant cost savings.

How will Wellgistics Health (WGRX) use XRP in its healthcare ecosystem?

WGRX will use XRP for real-time settlements between pharmacies and suppliers, smart rebates, XRP-backed credit lines for pharmacies, global vendor payouts, and compliance reporting.

What major institutional developments support Wellgistics Health's XRP initiative?

Recent developments include CME Group's upcoming XRP futures launch, Mastercard's endorsement of XRP for cross-border payments, Ripple's acquisition of Hidden Road, and regulatory licensing in Dubai.
Wellgistics Health Inc.

NASDAQ:WGRX

WGRX Rankings

WGRX Latest News

WGRX Stock Data

225.44M
900.00k
1.02%
0.04%
Pharmaceutical Retailers
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
TAMPA